Recognizing AK as a Chronic Condition
AK lesions take years to develop. During this time, they may appear as discolored rough patches on your skin. There is no cure for AK and if you have previously been diagnosed, it is likely that you will continue to develop new lesions over the years, even if your existing lesions have been treated and cleared up.
Actinic keratoses can become a serious health risk if left untreated and may develop into skin cancer later in life. Approximately 10% of AKs may eventually progress into squamous cell carcinoma (SCC) and approximately 60% of SCC began as untreated AKs. That is why many doctors consider AK to be a pre-cancerous condition and recommend treatment.
Fortunately, with early treatment, most AKs can be stopped from turning into skin cancer. Along with treatment, it's important to get serious about staying out of the sun—especially since AK is a chronic, or life-long, condition.
Important Product Safety Information
SOLARAZE® (diclofenac sodium-3%) Gel is indicated for the topical treatment of actinic keratoses (AKs).
Sun avoidance is indicated during SOLARAZE® Gel therapy. The safety of using sunscreens, cosmetics or topical medications while being treated with SOLARAZE® Gel is not known. Do not get SOLARAZE® Gel into eyes.
As with other non-steroidal anti-inflammatory drugs (NSAIDs), severe allergic reactions may occur in patients without prior exposure to diclofenac. Patients who are allergic or sensitive to aspirin and/or other NSAIDs, who also have asthma and nasal polyps, may have a condition known as the aspirin triad and should tell their doctor before beginning therapy.
SOLARAZE® Gel should be used with caution in patients with active stomach ulcers or bleeding and severe kidney or liver impairments. SOLARAZE® Gel should not be applied to open wounds, skin infections or any skin that shows signs of irritation.
In clinical trials, the most common adverse reactions involved the skin and included contact dermatitis, rash, dry skin and exfoliation (widespread reddened and peeling skin).
SOLARAZE® (diclofenac sodium-3%) Gel Full Prescribing Information.
